• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿液游离 DNA 的浓度和完整性指数作为早期肺癌诊断有前途的生物标志物。

Concentration and integrity indexes of urine cell-free DNA as promising biomarkers for early lung cancer diagnosis.

机构信息

Department of Laboratory Medicine, Daping Hospital, Army Medical University, Chongqing 400042, PR China.

Department of Pulmonology, Southwest Hospital, Army Medical University, Chongqing 400038, PR China.

出版信息

Per Med. 2021 Mar;18(2):129-139. doi: 10.2217/pme-2020-0019. Epub 2021 Feb 10.

DOI:10.2217/pme-2020-0019
PMID:33565322
Abstract

To explore the role of urine cell-free DNA (ucfDNA) concentration and integrity indexes as potential biomarkers for lung cancer diagnosis. Quantitative real-time PCR targeting Arthrobacter luteus () repeats at three size fragments (-60, 115 and 247 bp) was performed in 55 lung cancer patients and 35 healthy individuals. ucfDNA concentration and integrity indexes were significantly higher in lung cancer patients than in healthy controls. The area under the receiver operating characteristic curve for differentiating patients with stage I/II from healthy controls by fragments concentration were 0.856, 0.909 and 0.932, respectively. In addition, the ucfDNA integrity indexes in patients with lymph node metastasis were significantly higher than in patients with non-metastatic. ucfDNA concentration and integrity indexes could serve as promising biomarkers for lung cancer diagnosis.

摘要

目的

探讨尿游离 DNA(ucfDNA)浓度和完整性指标作为肺癌诊断潜在生物标志物的作用。

方法

采用针对节杆菌(Arthrobacter luteus)三个大小片段(-60、115 和 247bp)的实时定量 PCR 技术,对 55 例肺癌患者和 35 例健康个体进行检测。

结果

肺癌患者的 ucfDNA 浓度和完整性指标明显高于健康对照组。通过三条片段浓度区分 I/II 期患者与健康对照组的受试者工作特征曲线下面积分别为 0.856、0.909 和 0.932。此外,有淋巴结转移的患者的 ucfDNA 完整性指标明显高于无转移的患者。

结论

ucfDNA 浓度和完整性指标可作为肺癌诊断的有前途的生物标志物。

相似文献

1
Concentration and integrity indexes of urine cell-free DNA as promising biomarkers for early lung cancer diagnosis.尿液游离 DNA 的浓度和完整性指数作为早期肺癌诊断有前途的生物标志物。
Per Med. 2021 Mar;18(2):129-139. doi: 10.2217/pme-2020-0019. Epub 2021 Feb 10.
2
Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer.尿液游离 DNA 作为一种有前途的非小细胞肺癌早期检测生物标志物。
J Clin Lab Anal. 2020 Aug;34(8):e23321. doi: 10.1002/jcla.23321. Epub 2020 Apr 13.
3
Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.血浆无细胞 DNA 水平及其完整性作为鉴别非小细胞肺癌和结核的生物标志物。
Clin Chim Acta. 2018 Feb;477:160-165. doi: 10.1016/j.cca.2017.11.003. Epub 2017 Nov 4.
4
New method to preserve the original proportion and integrity of urinary cell-free DNA.保存尿液游离DNA原始比例和完整性的新方法。
J Clin Lab Anal. 2019 Feb;33(2):e22668. doi: 10.1002/jcla.22668. Epub 2018 Sep 2.
5
Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.循环游离DNA完整性作为乳腺癌和前列腺癌的诊断及预后标志物
Cancer Genet. 2019 Jun;235-236:65-71. doi: 10.1016/j.cancergen.2019.04.062. Epub 2019 Apr 23.
6
UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.尿液中的泛素结合酶E2C无细胞RNA能够区分膀胱癌和血尿。
Oncotarget. 2016 Sep 6;7(36):58193-58202. doi: 10.18632/oncotarget.11277.
7
Multiplexed real-time polymerase chain reaction cell-free DNA assay as a potential method to monitor stage IV colorectal cancer.多重实时聚合酶链反应无细胞 DNA 分析作为监测 IV 期结直肠癌的一种潜在方法。
Surgery. 2019 Oct;166(4):534-539. doi: 10.1016/j.surg.2019.06.004. Epub 2019 Aug 1.
8
Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.血浆微小RNA-195在非小细胞肺癌患者中的诊断和预后价值
World J Surg Oncol. 2016 Aug 24;14(1):224. doi: 10.1186/s12957-016-0980-8.
9
Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.唾液游离 DNA 的完整性和数量作为口腔癌潜在的分子生物标志物:一项初步研究。
J Oral Pathol Med. 2022 May;51(5):429-435. doi: 10.1111/jop.13299. Epub 2022 Apr 26.
10
Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA.通过循环游离DNA对73例胃癌患者的癌症进展进行预测。
BMC Cancer. 2016 Dec 9;16(1):943. doi: 10.1186/s12885-016-2977-7.

引用本文的文献

1
Diagnostic value of combined detection of plasma cfDNA concentration and integrity in NSCLC.血浆游离DNA浓度与完整性联合检测在非小细胞肺癌中的诊断价值
Lung Cancer Manag. 2024 May 16;13(1):LMT64. doi: 10.2217/lmt-2023-0009. eCollection 2024.
2
An Investigation into Cell-Free DNA in Different Common Cancers.循环游离 DNA 在常见癌症中的研究。
Mol Biotechnol. 2024 Dec;66(12):3462-3474. doi: 10.1007/s12033-023-00976-9. Epub 2023 Dec 10.
3
Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer.
血浆游离DNA(cfDNA)浓度、完整性与肿瘤标志物的组合是早期诊断非小细胞肺癌的有前景的生物标志物。
Heliyon. 2023 Oct 10;9(10):e20851. doi: 10.1016/j.heliyon.2023.e20851. eCollection 2023 Oct.
4
Non-Invasive Biomarkers for Early Lung Cancer Detection.用于早期肺癌检测的非侵入性生物标志物
Cancers (Basel). 2022 Nov 24;14(23):5782. doi: 10.3390/cancers14235782.
5
Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.唾液游离 DNA 的完整性和数量作为口腔癌潜在的分子生物标志物:一项初步研究。
J Oral Pathol Med. 2022 May;51(5):429-435. doi: 10.1111/jop.13299. Epub 2022 Apr 26.
6
ALU repeat as potential molecular marker in the detection and prognosis of different cancer types: A systematic review.ALU重复序列作为不同癌症类型检测和预后的潜在分子标志物:一项系统综述。
Mol Clin Oncol. 2022 Apr;16(4):86. doi: 10.3892/mco.2022.2519. Epub 2022 Feb 21.